Suchergebnisse - "Ma, Lili"

PubPharm (568)

91

Infantile Pompe disease with intrauterine onset: a case report and literature review

enthalten in: The Italian journal of pediatrics | 2022

von Xi, H. | Li, X. | Ma, L. | +3

92

Hydrocarbons removal and microbial community succession in petroleum-contaminated soil under hydrogen peroxide treatment

enthalten in: Environmental science and pollution research | 2022

von Yang, B. | Zhou, M. | Meng, Y. | +7

93

DDR1 promotes migration and invasion of breast cancer by modulating the Src-FAK signaling

enthalten in: Neoplasma | 2022

von Han, Q. | Xiao, F. | Ma, L. | +7

94

Efficient and selective adsorption of methylene blue and methyl violet dyes by yellow passion fruit peel

enthalten in: Environmental technology | 2022

von Lin, H. | Chen, K. | Du, L. | +4

95

Efficacy and safety of tofacitinib versus leflunomide with glucocorticoids treatment in Takayasu arteritis : A prospective study

enthalten in: Seminars in arthritis and rheumatism | 2022

von Wang, J. | Dai, X. | Ma, L. | +8

96

Eosinophilic granulomatosis with polyangiitis is associated with hepatitis B virus infection

enthalten in: Clinical rheumatology | 2022

von Liu, Y. | Dai, X. | Dong, Z. | +4

97

Investigation on the Synthesis, Application and Structural Features of Heteroaryl 1,2-Diketones

enthalten in: ACS omega | 2022

von Wehrle, R. | Rosen, A. | Nguyen, T. | +9

98

Hepatobiliary Tumor Organoids Reveal HLA Class I Neoantigen Landscape and Antitumoral Activity of Neoantigen Peptide Enhanced with Immune Checkpoint Inhibitors

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2022

von Wang, W. | Yuan, T. | Ma, L. | +15

99

Clinical characteristics, imaging phenotypes and events free survival in hypertensive Takayasu arteritis population

enthalten in: ResearchSquare.com | 2022

von Sun, Y. | Wu, S. | Wang, Y. | +5

100

Serum complement 3 is a potential biomarker for assessing disease activity in Takayasu arteritis

enthalten in: ResearchSquare.com | 2022

von Chen, R. | Ma, L. | Lv, P. | +10